Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) - 1 Sept 2009

Khoury-Shakour Sana, Lejbkowicz Flavio, Barnett-Griness Ofra, Tamir Ada, Pinchev Mila, Rennert Gad

Abstract excerpt

Earlier studies indicate that high circulating levels of insulin-like growth factor-1 (IGF-1) may be associated with premenopausal breast cancer. We studied variations in the IGF-1 gene and the growth hormone (GH1) gene in relation to risk of breast cancer in 667 Ashkenazi Jewish women (321 cases, 346 controls) from a population-based case-control study in Northern Israel, and a clinical series of 331 founder...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Growth Hormone

Share to Heterozygote

Share to Insulin-Like Growth Factor I

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 19543094
DOI: 10.1097/CEJ.0b013e32832e0942

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.PMID 19543094Read ↗

Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women.Semantic proximity Read ↗

The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.Semantic proximity Read ↗

Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.Semantic proximity Read ↗

BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.Semantic proximity Read ↗

Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers.Semantic proximity Read ↗

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.Semantic proximity Read ↗

Insulin-like Growth Factor 1 gene polymorphism and breast cancer risk.Semantic proximity Read ↗

FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.Semantic proximity Read ↗

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers.Semantic proximity Read ↗

Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.